• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Haisen Pharm(001367.SZ)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Oct21
Haisen Pharm released FY2025 Q3 earnings on October 21, 2025 (BJT), with actual revenue of CNY 116.78 M and EPS of CNY 0.18
15:00
Haisen Pharm released FY2025 9 Months earnings on October 21 (BJT), actual revenue CNY 358.87 M, actual EPS CNY 0.5799
15:00
Aug14
Haisen Pharm released FY2025 Semi-Annual Earnings on August 14 (BJT), actual revenue CNY 242.09 M, actual EPS CNY 0.4
15:00
Haisen Pharm released FY2025 Q2 earnings on August 14 (BJT), actual revenue CNY 123.61 M, actual EPS CNY 0.1972
15:00
Jul9
Huasen Pharmaceutical's ESG Rating Results Announced
01:14
Jul2
HSY Pharma's Director and Senior Executives ELin Reduce 479,800 Shares
13:02

Schedules & Filings

Schedules
Filings
Oct21
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 116.78 M, Net Income 27.42 M, EPS 0.18

Aug14
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 123.61 M, Net Income 29.58 M, EPS 0.1972

May20
Distribution Plan(CST)

Share conversion 4.8 for every 10 shrs held, Cash dividend 0.17 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More